Here's how we would trade the blue chip stock.
These promising companies look like good names for patient buy-and-hold investors.
CVS is an undervalued health care stock with a solid dividend yield above 3%.
It might be a good time to buy the stock because of its recent pullback, but there also is an ETF traders might consider if the telemedicine sector is of interest.
Could the charts be anticipating a peak in Teladoc health? Here's my strategy for this one.
Charts of HCA look constructive.
It also might give investors high blood pressure.
Technical analysis and trading strategy for the healthcare plan provider.
I found an interesting clue in one of the charts.
The charts are looking soft right now.